{
    "additionDate": "2020-01-09T18:01:24Z",
    "biotoolsCURIE": "biotools:B47",
    "biotoolsID": "B47",
    "confidence_flag": "high",
    "description": "Current Management of Malignant Colorectal Polyps Across a Regional United Kingdom Cancer Network.\n\nThe requested resource https://links.lww.com/_redirect.aspx?404;https://links.lww.com:443/DCR/B47.MANEJO was not found!.\n\n||| CORRECT NAME OF TOOL COULD ALSO BE 'polipos colorrectales malignos', 'polipos colorrectales malignos presentados'",
    "editPermission": {
        "type": "public"
    },
    "homepage": "http://links.lww.com/DCR/B47",
    "lastUpdate": "2020-01-09T18:01:24Z",
    "link": [
        {
            "type": [
                "Other"
            ],
            "url": "http://links.lww.com/DCR/B47.MANEJO"
        }
    ],
    "name": "B47",
    "owner": "Pub2Tools",
    "publication": [
        {
            "doi": "10.1097/DCR.0000000000001509",
            "metadata": {
                "abstract": "BACKGROUND: The incidence of malignant colorectal polyps has increased secondary to the greater use of diagnostic colonoscopy and introduction of screening programs. Faced with the dilemma of whether major resection is required or whether polypectomy has been sufficient treatment, the clinician relies on high- and low-risk histological parameters to guide decision-making. OBJECTIVE: The purpose of this study was to review current practice and evaluate multidisciplinary team decision-making across a United Kingdom Regional Cancer Network to establish the efficacy of previously set guidance from the Association of Coloproctology of Great Britain and Ireland (2013). DESIGN: This was a retrospective cohort study. SETTINGS: The study was conducted at a United Kingdom Regional Cancer Network composed of 4 separate National Health Service Hospital Trusts, covering an overall population of 1.5 million. PATIENTS: All patients with malignant colorectal polyps who presented to the colorectal multidisciplinary team over a 3-year period (April 1, 2012 to April 1, 2015) were included. MAIN OUTCOME MEASURES: Rate of residual disease after major resection, recurrence of cancer after polypectomy and surveillance alone, reporting of histological features, adherence to endoscopic surveillance guidelines, and outcomes of surveillance cross-sectional imaging were measured. RESULTS: A total of 173 patients (median age = 69 y) with a malignant colorectal polyp were identified during the study period, with a median of 2.7 years of follow-up. Thirty-seven patients (21.4%) underwent primary surgical resection with a residual disease rate of 43% (16/37). The remaining 136 patients (76.8%) were managed conservatively with recurrence in 6 cases (4.4%). Endoscopic follow-up at 3 months occurred in 61% of cases. Histological reporting was varied, with tumor differentiation and resection margin being reported in 84% of cases and lymphovascular invasion and depth of invasion in 71% and 59% of cases, respectively. LIMITATIONS: This was an observational retrospective study. CONCLUSIONS: The residual disease rate in patients treated surgically was higher than previously reported (43.2%). Incidence of recurrence in patients treated conservatively was low (4.4%). Areas of improvements have been identified in adherence to endoscopic follow-up, histopathological reporting, and potential overuse of radiological surveillance. See Video Abstract at http://links.lww.com/DCR/B47. MANEJO ACTUAL DE P\u00d3LIPOS COLORRECTALES MALIGNOS A TRAV\u00c9S DE UNA RED REGIONAL DE C\u00c1NCER DEL REINO UNIDO: La incidencia de p\u00f3lipos colorrectales malignos ha aumentado secundariamente al mayor uso de la colonoscopia diagn\u00f3stica y a la introducci\u00f3n de programas de detecci\u00f3n. Ante el dilema de si se requiere una resecci\u00f3n mayor o si la polipectom\u00eda ha sido un tratamiento suficiente, el m\u00e9dico se basa en par\u00e1metros histol\u00f3gicos de alto y bajo riesgo, para guiarse en la toma de decisiones.Revisar la pr\u00e1ctica actual y evaluar la toma de decisiones, del equipo multidisciplinario de una red regional de c\u00e1ncer del Reino Unido, para establecer la eficacia de las recomendaciones previamente establecidas, por la Asociaci\u00f3n de Coloproctolog\u00eda de la Gran Breta\u00f1a e Irlanda (2013).Estudio de cohorte retrospectivo.Red Regional del C\u00e1ncer del Reino Unido, que comprende cuatro Fideicomisos Hospitalarios del Servicio Nacional de Salud y que cubren una poblaci\u00f3n general de 1,5 millones de personas.Todos los pacientes con p\u00f3lipos colorrectales malignos presentados al equipo colorrectal multidisciplinario durante un per\u00edodo de 3 a\u00f1os (01/04/2012-01/04/2015).Tasa de enfermedad residual despu\u00e9s de una resecci\u00f3n mayor, recurrencia de c\u00e1ncer despu\u00e9s de polipectom\u00eda y vigilancia sola, informe de caracter\u00edsticas histol\u00f3gicas, adherencia a directrices de vigilancia endosc\u00f3pica y resultados de la vigilancia de la imagen transversal.Se identificaron un total de 173 pacientes (mediana de edad de 69 a\u00f1os) con p\u00f3lipo colorrectal maligno durante el per\u00edodo de estudio, con una mediana de seguimiento de 2.7 a\u00f1os. 37 pacientes (21,4%) fueron sometidos a resecci\u00f3n quir\u00fargica primaria con tasa de enfermedad residual del 43% (16/37). Los 136 pacientes restantes (76.8%) fueron manejados conservadoramente, con recurrencia en 6 casos (4.4%). El seguimiento endosc\u00f3pico a los 3 meses, ocurri\u00f3 en el 61% de los casos. El reporte histol\u00f3gico vari\u00f3 con la diferenciaci\u00f3n tumoral. El margen de resecci\u00f3n se inform\u00f3 en el 84% de los casos. La invasi\u00f3n linfovascular y la profundidad de la invasi\u00f3n fue del 71% y 59% de los casos.Estudio observacional retrospectivo.La tasa de enfermedad residual en pacientes tratados quir\u00fargicamente, fue m\u00e1s alta que la reportada previamente (43.2%). La incidencia de recurrencia en pacientes tratados de forma conservadora fue baja (4,4%). Se han identificado \u00e1reas de mejoras en cumplimiento del seguimiento endosc\u00f3pico, informe histopatol\u00f3gico y el posible uso excesivo de la vigilancia radiol\u00f3gica. Vea el Resumen del Video en http://links.lww.com/DCR/B47.",
                "authors": [
                    {
                        "name": "Sharma V."
                    },
                    {
                        "name": "Junejo M.A."
                    },
                    {
                        "name": "Mitchell P.J."
                    }
                ],
                "date": "2020-01-01T00:00:00Z",
                "journal": "Diseases of the colon and rectum",
                "title": "Current Management of Malignant Colorectal Polyps Across a Regional United Kingdom Cancer Network"
            },
            "pmid": "31569095"
        }
    ],
    "topic": [
        {
            "term": "Oncology",
            "uri": "http://edamontology.org/topic_2640"
        },
        {
            "term": "Medical imaging",
            "uri": "http://edamontology.org/topic_3384"
        }
    ]
}